[S02DA03, antipyrine, The serum concentration of Antipyrine can be decreased when it is combined with Dabrafenib.]
[G03XB02, ulipristal, The serum concentration of Ulipristal can be decreased when it is combined with Dabrafenib.]
[J01EC02, sulfadiazine, The serum concentration of Sulfadiazine can be decreased when it is combined with Dabrafenib.]
[S01AB01, sulfamethizole, The metabolism of Dabrafenib can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The serum concentration of Sulfamethoxazole can be decreased when it is combined with Dabrafenib.]
[J01EC03, sulfamoxole, The metabolism of Dabrafenib can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Dabrafenib can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The serum concentration of Sulfinpyrazone can be decreased when it is combined with Dabrafenib.]
[S01AB02, sulfisoxazole, The metabolism of Dabrafenib can be decreased when combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sulpiride.]
[M01AE07, suprofen, The serum concentration of Suprofen can be decreased when it is combined with Dabrafenib.]
[A10BB04, glibornuride, The serum concentration of Glibornuride can be decreased when it is combined with Dabrafenib.]
[A10BC01, glymidine, The therapeutic efficacy of Glymidine can be decreased when used in combination with Dabrafenib.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Dabrafenib.]
[L02BA01, tamoxifen, The serum concentration of Tamoxifen can be decreased when it is combined with Dabrafenib.]
[L01CB02, teniposide, The serum concentration of Teniposide can be decreased when it is combined with Dabrafenib.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Dabrafenib.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabrafenib can be increased when it is combined with Dabigatran etexilate.]
[G03BA03, testosterone, The serum concentration of Testosterone can be decreased when it is combined with Dabrafenib.]
[N07XX06, tetrabenazine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Tetracaine.]
[S03AA02, tetracycline, The serum concentration of Tetracycline can be decreased when it is combined with Dabrafenib.]
[N05AE05, lurasidone, The serum concentration of Lurasidone can be decreased when it is combined with Dabrafenib.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be decreased when it is combined with Dabrafenib.]
[N04BC07, apomorphine, The serum concentration of Apomorphine can be decreased when it is combined with Dabrafenib.]
[L04AX02, thalidomide, The serum concentration of Thalidomide can be decreased when it is combined with Dabrafenib.]
[R03DA04, theophylline, The serum concentration of Theophylline can be decreased when it is combined with Dabrafenib.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Dabrafenib.]
[L01AC01, thiotepa, The serum concentration of Thiotepa can be decreased when it is combined with Dabrafenib.]
[N05CA19, thiopental, The serum concentration of Thiopental can be decreased when it is combined with Dabrafenib.]
[N05AC02, thioridazine, The serum concentration of Thioridazine can be decreased when it is combined with Dabrafenib.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dabrafenib.]
[B01AC05, ticlopidine, The serum concentration of Ticlopidine can be decreased when it is combined with Dabrafenib.]
[S01ED01, timolol, The serum concentration of Timolol can be decreased when it is combined with Dabrafenib.]
[P01AB02, tinidazole, The serum concentration of Tinidazole can be decreased when it is combined with Dabrafenib.]
[A10BB05, tolazamide, The serum concentration of Tolazamide can be decreased when it is combined with Dabrafenib.]
[V04CA01, tolbutamide, The serum concentration of Tolbutamide can be decreased when it is combined with Dabrafenib.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Dabrafenib.]
[N06AF04, tranylcypromine, The metabolism of Dabrafenib can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Dabrafenib.]
[L01XF01, tretinoin, The risk or severity of adverse effects can be increased when Tretinoin is combined with Dabrafenib.]
[S01BA05, triamcinolone, The serum concentration of Triamcinolone can be decreased when it is combined with Dabrafenib.]
[N05CD05, triazolam, The serum concentration of Triazolam can be decreased when it is combined with Dabrafenib.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Dabrafenib.]
[S01BA09, clobetasone, The serum concentration of Clobetasone can be decreased when it is combined with Dabrafenib.]
[S01BA10, alclometasone, The serum concentration of Alclometasone can be decreased when it is combined with Dabrafenib.]
[R03BA07, mometasone, The serum concentration of Mometasone can be decreased when it is combined with Dabrafenib.]
[A03AA05, trimebutine, The serum concentration of Trimebutine can be decreased when it is combined with Dabrafenib.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Dabrafenib.]
[N03AC02, trimethadione, The serum concentration of Trimethadione can be decreased when it is combined with Dabrafenib.]
[J01EA01, trimethoprim, The serum concentration of Trimethoprim can be decreased when it is combined with Dabrafenib.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be decreased when it is combined with Dabrafenib.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Dabrafenib.]
[J01FA08, troleandomycin, The serum concentration of Dabrafenib can be increased when it is combined with Troleandomycin.]
[N06AX24, vilazodone, The serum concentration of Vilazodone can be decreased when it is combined with Dabrafenib.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be decreased when it is combined with Dabrafenib.]
[L01EX04, vandetanib, The serum concentration of Vandetanib can be decreased when it is combined with Dabrafenib.]
[L02BX03, abiraterone, The serum concentration of Abiraterone can be decreased when it is combined with Dabrafenib.]
[A10BH05, linagliptin, The serum concentration of Linagliptin can be decreased when it is combined with Dabrafenib.]
[J05AP03, boceprevir, The serum concentration of Dabrafenib can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The serum concentration of Dabrafenib can be increased when it is combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Dabrafenib.]
[N03AX21, ezogabine, The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Dabrafenib.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be decreased when it is combined with Dabrafenib.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be decreased when it is combined with Dabrafenib.]
[B01AC24, ticagrelor, The serum concentration of Ticagrelor can be decreased when it is combined with Dabrafenib.]
[C08DA01, verapamil, The serum concentration of Verapamil can be decreased when it is combined with Dabrafenib.]
[N06AX09, viloxazine, The metabolism of Dabrafenib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be decreased when it is combined with Dabrafenib.]
[L01CA02, vincristine, The serum concentration of Vincristine can be decreased when it is combined with Dabrafenib.]
[L01CA03, vindesine, The serum concentration of Vindesine can be decreased when it is combined with Dabrafenib.]
[A11HA03, vitamin E, The serum concentration of Vitamin E can be decreased when it is combined with Dabrafenib.]
[B01AA03, warfarin, The serum concentration of Warfarin can be decreased when it is combined with Dabrafenib.]
[J05AF01, zidovudine, The serum concentration of Zidovudine can be decreased when it is combined with Dabrafenib.]
[N05AF05, zuclopenthixol, The serum concentration of Zuclopenthixol can be decreased when it is combined with Dabrafenib.]
[J05AE02, indinavir, The serum concentration of Dabrafenib can be increased when it is combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Dabrafenib can be increased when it is combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be decreased when it is combined with Dabrafenib.]
[L01ED01, crizotinib, The metabolism of Dabrafenib can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The serum concentration of Zafirlukast can be decreased when it is combined with Dabrafenib.]
[A02BC04, rabeprazole, The serum concentration of Rabeprazole can be decreased when it is combined with Dabrafenib.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Dabrafenib.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ziprasidone.]
[G03AC10, drospirenone, The serum concentration of Drospirenone can be decreased when it is combined with Dabrafenib.]
[S01LA01, verteporfin, Dabrafenib may increase the photosensitizing activities of Verteporfin.]
[N02BA01, aspirin, The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Dabrafenib.]
[L01EJ01, ruxolitinib, The serum concentration of Ruxolitinib can be decreased when it is combined with Dabrafenib.]
[G04BD07, tolterodine, The serum concentration of Tolterodine can be decreased when it is combined with Dabrafenib.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Dabrafenib.]
[J02AC03, voriconazole, The serum concentration of Voriconazole can be decreased when it is combined with Dabrafenib.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Atropine.]
[L01XJ01, vismodegib, The serum concentration of Vismodegib can be decreased when it is combined with Dabrafenib.]
[L01EK01, axitinib, The serum concentration of Axitinib can be decreased when it is combined with Dabrafenib.]
[R07AX02, ivacaftor, The serum concentration of Ivacaftor can be decreased when it is combined with Dabrafenib.]
[H02AB11, prednylidene, The serum concentration of Prednylidene can be decreased when it is combined with Dabrafenib.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Dabrafenib.]
[L01BC05, gemcitabine, The serum concentration of Dabrafenib can be increased when it is combined with Gemcitabine.]
[G04BE10, avanafil, The serum concentration of Avanafil can be decreased when it is combined with Dabrafenib.]
[A08AA11, lorcaserin, The serum concentration of Lorcaserin can be decreased when it is combined with Dabrafenib.]
[G04BD12, mirabegron, The serum concentration of Mirabegron can be decreased when it is combined with Dabrafenib.]
[L01XG02, carfilzomib, The serum concentration of Dabrafenib can be increased when it is combined with Carfilzomib.]
[V03AX03, cobicistat, The serum concentration of Dabrafenib can be increased when it is combined with Cobicistat.]
[J05AJ02, elvitegravir, The serum concentration of Dabrafenib can be increased when it is combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Enzalutamide can be increased when it is combined with Dabrafenib.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be decreased when it is combined with Dabrafenib.]
[L04AA31, teriflunomide, The metabolism of Dabrafenib can be decreased when combined with Teriflunomide.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AC02, calcium silicate, Calcium silicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AA01, aldosterone, The serum concentration of Aldosterone can be decreased when it is combined with Dabrafenib.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be decreased when it is combined with Dabrafenib.]
[N05CA04, barbital, The serum concentration of Barbital can be decreased when it is combined with Dabrafenib.]
[J05AE04, nelfinavir, The serum concentration of Dabrafenib can be increased when it is combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Dabrafenib.]
[C08CA13, lercanidipine, The serum concentration of Lercanidipine can be decreased when it is combined with Dabrafenib.]
[N06DA02, donepezil, The serum concentration of Donepezil can be decreased when it is combined with Dabrafenib.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Dabrafenib.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Dabrafenib.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Dabrafenib.]
[G04BD10, darifenacin, The serum concentration of Darifenacin can be decreased when it is combined with Dabrafenib.]
[L01EX07, cabozantinib, The serum concentration of Cabozantinib can be decreased when it is combined with Dabrafenib.]
[H01CB05, pasireotide, The metabolism of Dabrafenib can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Sildenafil can be decreased when it is combined with Dabrafenib.]
[L01EA05, ponatinib, The serum concentration of Ponatinib can be decreased when it is combined with Dabrafenib.]
[B01AF02, apixaban, The serum concentration of Apixaban can be decreased when it is combined with Dabrafenib.]
[C10AX12, lomitapide, The serum concentration of Lomitapide can be decreased when it is combined with Dabrafenib.]
[J04AK05, bedaquiline, The serum concentration of Bedaquiline can be decreased when it is combined with Dabrafenib.]
[C04AX11, bencyclane, The serum concentration of Bencyclane can be decreased when it is combined with Dabrafenib.]
[A10BH04, alogliptin, The serum concentration of Alogliptin can be decreased when it is combined with Dabrafenib.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Dabrafenib can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be decreased when it is combined with Dabrafenib.]
[G03XC05, ospemifene, The serum concentration of Ospemifene can be decreased when it is combined with Dabrafenib.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be decreased when it is combined with Dabrafenib.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Gemifloxacin.]
[M04AB03, benzbromarone, The metabolism of Dabrafenib can be decreased when combined with Benzbromarone.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Moxifloxacin.]
[A06AX06, tegaserod, The metabolism of Dabrafenib can be decreased when combined with Tegaserod.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Dabrafenib.]
[R02AD01, benzocaine, The serum concentration of Benzocaine can be decreased when it is combined with Dabrafenib.]
[A10BX05, pramlintide, The therapeutic efficacy of Pramlintide can be decreased when used in combination with Dabrafenib.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Dabrafenib.]
[M01AH01, celecoxib, The serum concentration of Celecoxib can be decreased when it is combined with Dabrafenib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be decreased when it is combined with Dabrafenib.]
[N04AC01, benztropine, The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dabrafenib.]
[S01AA13, fusidic acid, The serum concentration of Fusidic acid can be decreased when it is combined with Dabrafenib.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Pipemidic acid.]
[L01EE01, trametinib, The risk or severity of adverse effects can be increased when Trametinib is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The serum concentration of Benzyl alcohol can be decreased when it is combined with Dabrafenib.]
[L01EB03, afatinib, The serum concentration of Dabrafenib can be increased when it is combined with Afatinib.]
[N06AX28, levomilnacipran, The serum concentration of Levomilnacipran can be decreased when it is combined with Dabrafenib.]
[J05AJ03, dolutegravir, Dabrafenib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C08EA02, bepridil, The serum concentration of Bepridil can be decreased when it is combined with Dabrafenib.]
[C02KX05, riociguat, The serum concentration of Riociguat can be decreased when it is combined with Dabrafenib.]
[A10BJ03, lixisenatide, The therapeutic efficacy of Lixisenatide can be decreased when used in combination with Dabrafenib.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Dabrafenib.]
[G03XC02, bazedoxifene, The metabolism of Bazedoxifene can be decreased when combined with Dabrafenib.]
[C02KX04, macitentan, The serum concentration of Macitentan can be decreased when it is combined with Dabrafenib.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Dabrafenib.]
[N06AX26, vortioxetine, The serum concentration of Vortioxetine can be decreased when it is combined with Dabrafenib.]
[G03AC08, etonogestrel, The serum concentration of Etonogestrel can be decreased when it is combined with Dabrafenib.]
[N03AF04, eslicarbazepine, The metabolism of Dabrafenib can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Simeprevir can be decreased when it is combined with Dabrafenib.]
[J05AP08, sofosbuvir, Dabrafenib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, The serum concentration of Dapagliflozin can be decreased when it is combined with Dabrafenib.]
[N05CH03, tasimelteon, The serum concentration of Tasimelteon can be decreased when it is combined with Dabrafenib.]
[A16AA07, metreleptin, The metabolism of Dabrafenib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The serum concentration of Apremilast can be decreased when it is combined with Dabrafenib.]
[L02BG02, formestane, The metabolism of Dabrafenib can be increased when combined with Formestane.]
[S03BA03, betamethasone, The serum concentration of Betamethasone can be decreased when it is combined with Dabrafenib.]
[C10AB02, bezafibrate, The serum concentration of Bezafibrate can be decreased when it is combined with Dabrafenib.]
[A10BJ04, albiglutide, The therapeutic efficacy of Albiglutide can be decreased when used in combination with Dabrafenib.]
[L04AC11, siltuximab, The metabolism of Dabrafenib can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be decreased when it is combined with Dabrafenib.]
[B01AC26, vorapaxar, The serum concentration of Vorapaxar can be decreased when it is combined with Dabrafenib.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dabrafenib.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be decreased when it is combined with Dabrafenib.]
[L01XH04, belinostat, The metabolism of Belinostat can be decreased when combined with Dabrafenib.]
[L01EM01, idelalisib, The serum concentration of Idelalisib can be decreased when it is combined with Dabrafenib.]
[N07XX08, tafamidis, The serum concentration of Dabrafenib can be increased when it is combined with Tafamidis.]
[A10BK03, empagliflozin, The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Dabrafenib.]
[R03AC19, olodaterol, The serum concentration of Olodaterol can be decreased when it is combined with Dabrafenib.]
[N05CM19, suvorexant, The serum concentration of Suvorexant can be decreased when it is combined with Dabrafenib.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Dabrafenib.]
[J01XA05, oritavancin, The metabolism of Dabrafenib can be increased when combined with Oritavancin.]
[A10BJ05, dulaglutide, The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Dabrafenib.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be decreased when it is combined with Dabrafenib.]
[A11HA08, tocophersolan, The serum concentration of Tocofersolan can be decreased when it is combined with Dabrafenib.]
[L04AX05, pirfenidone, The serum concentration of Pirfenidone can be decreased when it is combined with Dabrafenib.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be decreased when it is combined with Dabrafenib.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Dabrafenib.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be decreased when it is combined with Dabrafenib.]
[L01XK01, olaparib, The serum concentration of Olaparib can be decreased when it is combined with Dabrafenib.]
[B01AA01, dicumarol, The serum concentration of Dicoumarol can be decreased when it is combined with Dabrafenib.]
[B01AF03, edoxaban, The serum concentration of Dabrafenib can be increased when it is combined with Edoxaban.]
[N06AX11, mirtazapine, The serum concentration of Mirtazapine can be decreased when it is combined with Dabrafenib.]
[L04AC10, secukinumab, The metabolism of Dabrafenib can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The serum concentration of Palbociclib can be decreased when it is combined with Dabrafenib.]
[L01EX08, lenvatinib, Dabrafenib may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be decreased when it is combined with Dabrafenib.]
[J05AP07, daclatasvir, The serum concentration of Daclatasvir can be decreased when it is combined with Dabrafenib.]
[N02BE01, acetaminophen, The serum concentration of Acetaminophen can be decreased when it is combined with Dabrafenib.]
[C01EB17, ivabradine, The serum concentration of Ivabradine can be decreased when it is combined with Dabrafenib.]
[J05AP06, asunaprevir, The serum concentration of Asunaprevir can be decreased when it is combined with Dabrafenib.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Dabrafenib.]
[N05AX16, brexpiprazole, The serum concentration of Brexpiprazole can be decreased when it is combined with Dabrafenib.]
[L01XJ02, sonidegib, The serum concentration of Sonidegib can be decreased when it is combined with Dabrafenib.]
[A04AD14, rolapitant, The serum concentration of Rolapitant can be decreased when it is combined with Dabrafenib.]
[G02CX02, flibanserin, The serum concentration of Flibanserin can be decreased when it is combined with Dabrafenib.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX15, cariprazine, The serum concentration of Cariprazine can be decreased when it is combined with Dabrafenib.]
[A10BF01, acarbose, The therapeutic efficacy of Acarbose can be decreased when used in combination with Dabrafenib.]
[S01EC01, acetazolamide, The metabolism of Dabrafenib can be decreased when combined with Acetazolamide.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Dabrafenib.]
[A02BC03, lansoprazole, The serum concentration of Lansoprazole can be decreased when it is combined with Dabrafenib.]
[L01CX01, trabectedin, The serum concentration of Trabectedin can be decreased when it is combined with Dabrafenib.]
[J02AC05, isavuconazole, The serum concentration of Isavuconazole can be decreased when it is combined with Dabrafenib.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be decreased when it is combined with Dabrafenib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Dabrafenib.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Dabrafenib.]
[L01XG03, ixazomib, The serum concentration of Ixazomib can be decreased when it is combined with Dabrafenib.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Dabrafenib.]
[B01AC27, selexipag, The serum concentration of Selexipag can be decreased when it is combined with Dabrafenib.]
[A10BB31, acetohexamide, The serum concentration of Acetohexamide can be decreased when it is combined with Dabrafenib.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be decreased when combined with Dabrafenib.]
[M04AB05, lesinurad, The serum concentration of Lesinurad can be decreased when it is combined with Dabrafenib.]
[J05AP10, elbasvir, The serum concentration of Elbasvir can be decreased when it is combined with Dabrafenib.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be decreased when it is combined with Dabrafenib.]
[N05CA05, aprobarbital, The metabolism of Dabrafenib can be increased when combined with Aprobarbital.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AX23, brivaracetam, The serum concentration of Brivaracetam can be decreased when it is combined with Dabrafenib.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be decreased when it is combined with Dabrafenib.]
[N04BC01, bromocriptine, The serum concentration of Bromocriptine can be decreased when it is combined with Dabrafenib.]
[A02AD05, aluminum magnesium silicate, Almasilate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[D07AC11, amcinonide, The serum concentration of Amcinonide can be decreased when it is combined with Dabrafenib.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Dabrafenib.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Dabrafenib.]
[N05AX17, pimavanserin, The serum concentration of Pimavanserin can be decreased when it is combined with Dabrafenib.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Dabrafenib.]
[N01BB01, bupivacaine, The serum concentration of Bupivacaine can be decreased when it is combined with Dabrafenib.]
[C07AA19, bupranolol, The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dabrafenib.]
[N07BC01, buprenorphine, The serum concentration of Buprenorphine can be decreased when it is combined with Dabrafenib.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Dabrafenib.]
[N05BE01, buspirone, The serum concentration of Buspirone can be decreased when it is combined with Dabrafenib.]
[L01AB01, busulfan, The serum concentration of Busulfan can be decreased when it is combined with Dabrafenib.]
[L01XX27, arsenic trioxide, The serum concentration of Dabrafenib can be increased when it is combined with Arsenic trioxide.]
[P01BE02, artemether, The serum concentration of Artemether can be decreased when it is combined with Dabrafenib.]
[M02AA03, clofezone, The serum concentration of Rabeprazole can be decreased when it is combined with Dabrafenib.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Dabrafenib.]
[S01GX07, azelastine, The serum concentration of Azelastine can be decreased when it is combined with Dabrafenib.]
[L01XK03, rucaparib, The serum concentration of Rucaparib can be decreased when it is combined with Dabrafenib.]
[S01AA26, azithromycin, The serum concentration of Azithromycin can be decreased when it is combined with Dabrafenib.]
[L01EF02, ribociclib, The serum concentration of Dabrafenib can be increased when it is combined with Ribociclib.]
[N07XX16, deutetrabenazine, The serum concentration of Deutetrabenazine can be decreased when it is combined with Dabrafenib.]
[N02BF02, pregabalin, The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dabrafenib.]
[N06BC01, caffeine, Caffeine may decrease the excretion rate of Dabrafenib which could result in a higher serum level.]
[A10BX06, benfluorex, The therapeutic efficacy of Benfluorex can be decreased when used in combination with Dabrafenib.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The serum concentration of Calcitriol can be decreased when it is combined with Dabrafenib.]
[A12AA04, calcium carbonate, Calcium carbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J05AF06, abacavir, The metabolism of Abacavir can be decreased when combined with Dabrafenib.]
[J05AE09, tipranavir, The serum concentration of Dabrafenib can be increased when it is combined with Tipranavir.]
[N07XX13, valbenazine, The serum concentration of Valbenazine can be decreased when it is combined with Dabrafenib.]
[L04AB02, infliximab, The metabolism of Dabrafenib can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The serum concentration of Dabrafenib can be increased when it is combined with Midostaurin.]
[L01ED04, brigatinib, The serum concentration of Brigatinib can be decreased when it is combined with Dabrafenib.]
[N04BD03, safinamide, The serum concentration of Safinamide can be decreased when it is combined with Dabrafenib.]
[L04AC14, sarilumab, The metabolism of Dabrafenib can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Dabrafenib can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The serum concentration of Dabrafenib can be increased when it is combined with Betrixaban.]
[D01AC10, bifonazole, The metabolism of Dabrafenib can be decreased when combined with Bifonazole.]
[P03AC02, bioallethrin, The serum concentration of Bioallethrin can be decreased when it is combined with Dabrafenib.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Dabrafenib.]
[L01XX59, enasidenib, The serum concentration of Enasidenib can be decreased when it is combined with Dabrafenib.]
[L01EH02, neratinib, The serum concentration of Neratinib can be decreased when it is combined with Dabrafenib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Dabrafenib can be increased when it is combined with Inotuzumab ozogamicin.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dabrafenib.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be decreased when it is combined with Dabrafenib.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be decreased when it is combined with Dabrafenib.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be decreased when it is combined with Dabrafenib.]
[S01EC04, brinzolamide, The serum concentration of Brinzolamide can be decreased when it is combined with Dabrafenib.]
[J05AG03, efavirenz, The serum concentration of Dabrafenib can be increased when it is combined with Efavirenz.]
[N05CD09, brotizolam, The serum concentration of Brotizolam can be decreased when it is combined with Dabrafenib.]
[R03BA02, budesonide, The serum concentration of Budesonide can be decreased when it is combined with Dabrafenib.]
[L01EL02, acalabrutinib, The serum concentration of Acalabrutinib can be decreased when it is combined with Dabrafenib.]
[J05AX18, letermovir, The metabolism of Dabrafenib can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Acetyldigoxin.]
[A10BJ06, semaglutide, The therapeutic efficacy of Semaglutide can be decreased when used in combination with Dabrafenib.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Capsaicin.]
[A10BK04, ertugliflozin, The therapeutic efficacy of Ertugliflozin can be decreased when used in combination with Dabrafenib.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Acrivastine.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Dabrafenib.]
[V04CD06, macimorelin, The serum concentration of Macimorelin can be decreased when it is combined with Dabrafenib.]
[L02BB05, apalutamide, The serum concentration of Apalutamide can be increased when it is combined with Dabrafenib.]
[N03AF01, carbamazepine, The serum concentration of Carbamazepine can be decreased when it is combined with Dabrafenib.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Carbinoxamine.]
[C07AG02, carvedilol, The serum concentration of Carvedilol can be decreased when it is combined with Dabrafenib.]
[B02BX09, fostamatinib, The serum concentration of Fostamatinib can be decreased when it is combined with Dabrafenib.]
[N03AX24, cannabidiol, The serum concentration of Cannabidiol can be decreased when it is combined with Dabrafenib.]
[B02BX08, avatrombopag, The metabolism of Dabrafenib can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Dabrafenib.]
[V03AE10, sodium zirconium cyclosilicate, Sodium zirconium cyclosilicate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01EC03, encorafenib, The serum concentration of Encorafenib can be decreased when it is combined with Dabrafenib.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Dabrafenib.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Dabrafenib.]
[C07AB08, celiprolol, The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Dabrafenib.]
[H01CC03, elagolix, The serum concentration of Elagolix can be decreased when it is combined with Dabrafenib.]
[L01XX62, ivosidenib, The metabolism of Dabrafenib can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, The metabolism of Migalastat can be decreased when combined with Dabrafenib.]
[N03AX17, stiripentol, The metabolism of Dabrafenib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, Dabrafenib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[J05AX24, tecovirimat, The metabolism of Dabrafenib can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The serum concentration of Doravirine can be decreased when it is combined with Dabrafenib.]
[J01AA13, eravacycline, The serum concentration of Eravacycline can be decreased when it is combined with Dabrafenib.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be decreased when it is combined with Dabrafenib.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be decreased when it is combined with Dabrafenib.]
[J01AA14, sarecycline, The serum concentration of Dabrafenib can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Dabrafenib can be increased when it is combined with Omadacycline.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Dabrafenib.]
[A10BB06, carbutamide, The serum concentration of Carbutamide can be decreased when it is combined with Dabrafenib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The serum concentration of Lornoxicam can be decreased when it is combined with Dabrafenib.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Inotersen.]
[L01XK04, talazoparib, Dabrafenib may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[M03BA02, carisoprodol, The serum concentration of Carisoprodol can be decreased when it is combined with Dabrafenib.]
[R03BB08, revefenacin, Dabrafenib may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The serum concentration of Lorlatinib can be decreased when it is combined with Dabrafenib.]
[L04AA39, emapalumab, The metabolism of Dabrafenib can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be decreased when it is combined with Dabrafenib.]
[L01EX13, gilteritinib, The serum concentration of Gilteritinib can be decreased when it is combined with Dabrafenib.]
[L01XJ03, glasdegib, The serum concentration of Glasdegib can be decreased when it is combined with Dabrafenib.]
[N07XX05, amifampridine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Amifampridine.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be decreased when it is combined with Dabrafenib.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Cibenzoline.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Dabrafenib.]
[P02BX04, triclabendazole, The serum concentration of Triclabendazole can be decreased when it is combined with Dabrafenib.]
[N06AX27, esketamine, The serum concentration of Esketamine can be decreased when it is combined with Dabrafenib.]
[L04AA42, siponimod, The serum concentration of Siponimod can be decreased when it is combined with Dabrafenib.]
[J01FA09, clarithromycin, The serum concentration of Dabrafenib can be increased when it is combined with Clarithromycin.]
[N06BA14, solriamfetol, The serum concentration of Solriamfetol can be increased when it is combined with Dabrafenib.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Dabrafenib.]
[N05BA09, clobazam, The serum concentration of Clobazam can be decreased when it is combined with Dabrafenib.]
[H02AB14, cloprednol, The metabolism of Dabrafenib can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The serum concentration of Candesartan can be decreased when it is combined with Dabrafenib.]
[L04AB01, etanercept, The metabolism of Dabrafenib can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Dabrafenib can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Dabrafenib.]
[L01FX14, polatuzumab vedotin, The serum concentration of Polatuzumab vedotin can be decreased when it is combined with Dabrafenib.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Dabrafenib.]
[L01XX66, selinexor, The serum concentration of Selinexor can be decreased when it is combined with Dabrafenib.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Dabrafenib.]
[L02BB06, darolutamide, The serum concentration of Dabrafenib can be increased when it is combined with Darolutamide.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Dabrafenib.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Dabrafenib.]
[C03BX03, cicletanine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Cicletanine.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Dabrafenib.]
[M03BX08, cyclobenzaprine, The serum concentration of Cyclobenzaprine can be decreased when it is combined with Dabrafenib.]
[L04AA44, upadacitinib, The serum concentration of Upadacitinib can be decreased when it is combined with Dabrafenib.]
[L01EJ02, fedratinib, The serum concentration of Fedratinib can be decreased when it is combined with Dabrafenib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Dabrafenib.]
[N07XX11, pitolisant, The serum concentration of Dabrafenib can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The serum concentration of Pretomanid can be decreased when it is combined with Dabrafenib.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Dabrafenib.]
[N04CX01, istradefylline, The serum concentration of Istradefylline can be decreased when it is combined with Dabrafenib.]
[G04BE04, yohimbine, The serum concentration of Yohimbine can be decreased when it is combined with Dabrafenib.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Dabrafenib.]
[J01XX09, daptomycin, The serum concentration of Dabrafenib can be increased when it is combined with Daptomycin.]
[J01DB01, cephalexin, The serum concentration of Cephalexin can be decreased when it is combined with Dabrafenib.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Dabrafenib.]
[J01DB09, cephradine, The metabolism of Dabrafenib can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Dabrafenib.]
[G03DB05, demegestone, The serum concentration of Demegestone can be decreased when it is combined with Dabrafenib.]
[N02CC08, lasmiditan, The serum concentration of Dabrafenib can be increased when it is combined with Lasmiditan.]
[L01EL03, zanubrutinib, The serum concentration of Zanubrutinib can be decreased when it is combined with Dabrafenib.]
[G03AC09, desogestrel, The serum concentration of Desogestrel can be decreased when it is combined with Dabrafenib.]
[B06AX03, voxelotor, The serum concentration of Dabrafenib can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Cenobamate can be decreased when it is combined with Dabrafenib.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Dabrafenib.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be decreased when it is combined with Dabrafenib.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Dabrafenib.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dexchlorpheniramine.]
[L01EX18, avapritinib, The serum concentration of Avapritinib can be decreased when it is combined with Dabrafenib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Dabrafenib.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be decreased when it is combined with Dabrafenib.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Dabrafenib.]
[M01AX21, diacetylrhein, The metabolism of Dabrafenib can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Dabrafenib.]
[C10AX15, bempedoic acid, The excretion of Bempedoic acid can be decreased when combined with Dabrafenib.]
[J05AB16, remdesivir, The serum concentration of Remdesivir can be decreased when it is combined with Dabrafenib.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dabrafenib.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be decreased when it is combined with Dabrafenib.]
[J05AE05, amprenavir, The serum concentration of Dabrafenib can be increased when it is combined with Amprenavir.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Dabrafenib.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Dabrafenib.]
[G03DB08, dienogest, The serum concentration of Dienogest can be decreased when it is combined with Dabrafenib.]
[D07AC19, difluprednate, The serum concentration of Difluprednate can be decreased when it is combined with Dabrafenib.]
[L01XD01, porfimer sodium, Dabrafenib may increase the photosensitizing activities of Porfimer sodium.]
[N02AA08, dihydrocodeine, The serum concentration of Dihydrocodeine can be decreased when it is combined with Dabrafenib.]
[N02CC06, eletriptan, The serum concentration of Eletriptan can be decreased when it is combined with Dabrafenib.]
[M01AH02, rofecoxib, The serum concentration of Rofecoxib can be decreased when it is combined with Dabrafenib.]
[L01XF03, bexarotene, The serum concentration of Bexarotene can be decreased when it is combined with Dabrafenib.]
[C08CA16, clevidipine, The serum concentration of Clevidipine can be decreased when it is combined with Dabrafenib.]
[C01BD07, dronedarone, The serum concentration of Dabrafenib can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Dabrafenib can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Dabrafenib can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Chlorcyclizine.]
[L01EN02, pemigatinib, The serum concentration of Pemigatinib can be decreased when it is combined with Dabrafenib.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be increased when it is combined with Dabrafenib.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Dabrafenib.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Dabrafenib.]
[D07XB03, fluprednidene, The serum concentration of Fluprednidene can be decreased when it is combined with Dabrafenib.]
[P01BE01, artemisinin, The serum concentration of Artemisinin can be decreased when it is combined with Dabrafenib.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be decreased when it is combined with Dabrafenib.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be increased when it is combined with Dabrafenib.]
[N05CM02, chlormethiazole, The serum concentration of Clomethiazole can be decreased when it is combined with Dabrafenib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Dyclonine.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Dabrafenib.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Dabrafenib.]
[R06AX22, ebastine, The serum concentration of Ebastine can be decreased when it is combined with Dabrafenib.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be decreased when it is combined with Dabrafenib.]
[P01BB01, proguanil, The serum concentration of Proguanil can be decreased when it is combined with Dabrafenib.]
[L01FX15, belantamab mafodotin, The serum concentration of Dabrafenib can be increased when it is combined with Belantamab mafodotin.]
[L04AC19, satralizumab, The serum concentration of Dabrafenib can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be decreased when it is combined with Dabrafenib.]
[P01BA01, chloroquine, The serum concentration of Chloroquine can be decreased when it is combined with Dabrafenib.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be decreased when it is combined with Dabrafenib.]
[R06AB04, chlorpheniramine, The serum concentration of Chlorpheniramine can be decreased when it is combined with Dabrafenib.]
[N05AA01, chlorpromazine, The serum concentration of Chlorpromazine can be decreased when it is combined with Dabrafenib.]
[A10BB02, chlorpropamide, The serum concentration of Chlorpropamide can be decreased when it is combined with Dabrafenib.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dabrafenib.]
[M03BB03, chlorzoxazone, The serum concentration of Chlorzoxazone can be decreased when it is combined with Dabrafenib.]
[A11CC05, cholecalciferol, The serum concentration of Cholecalciferol can be decreased when it is combined with Dabrafenib.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Dabrafenib.]
[N02BA03, choline salicylate, The serum concentration of Choline salicylate can be increased when it is combined with Dabrafenib.]
[N06BX18, vinpocetine, The serum concentration of Vinpocetine can be decreased when it is combined with Dabrafenib.]
[G03DC06, ethynodiol, The serum concentration of Etynodiol can be decreased when it is combined with Dabrafenib.]
[M01AB08, etodolac, The serum concentration of Etodolac can be decreased when it is combined with Dabrafenib.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Dabrafenib.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Dabrafenib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Dabrafenib.]
[J05AJ04, cabotegravir, The metabolism of Cabotegravir can be decreased when combined with Dabrafenib.]
[L04AD03, voclosporin, The serum concentration of Dabrafenib can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Dabrafenib can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Dabrafenib can be increased when it is combined with Tepotinib.]
[L01EX25, umbralisib, The serum concentration of Dabrafenib can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, Dabrafenib may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, The serum concentration of Felbamate can be decreased when it is combined with Dabrafenib.]
[G04CB01, finasteride, The serum concentration of Finasteride can be decreased when it is combined with Dabrafenib.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Dabrafenib.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Flumequine.]
[R03BA03, flunisolide, The serum concentration of Flunisolide can be decreased when it is combined with Dabrafenib.]
[S02BA08, fluocinolone acetonide, The serum concentration of Fluocinolone acetonide can be decreased when it is combined with Dabrafenib.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Dabrafenib.]
[R03CC15, formoterol, The serum concentration of Formoterol can be decreased when it is combined with Dabrafenib.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Dabrafenib.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Dabrafenib.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Dabrafenib.]
[L03AB10, peginterferon alfa-2b, The metabolism of Dabrafenib can be increased when combined with Peginterferon alfa-2b.]
[L01FX22, loncastuximab tesirine, The serum concentration of Dabrafenib can be increased when it is combined with Loncastuximab tesirine.]
[A02BA01, cimetidine, Cimetidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N07CA02, cinnarizine, The serum concentration of Cinnarizine can be decreased when it is combined with Dabrafenib.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Dabrafenib can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The serum concentration of Infigratinib can be decreased when it is combined with Dabrafenib.]
[S03AA07, ciprofloxacin, The metabolism of Dabrafenib can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Dabrafenib.]
[N06AB04, citalopram, The serum concentration of Citalopram can be decreased when it is combined with Dabrafenib.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Dabrafenib.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Dabrafenib.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Dabrafenib.]
[P01CA03, fexinidazole, The serum concentration of Fexinidazole can be decreased when it is combined with Dabrafenib.]
[L01XX74, belzutifan, The serum concentration of Dabrafenib can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mobocertinib.]
[L01FX23, tisotumab vedotin, The serum concentration of Tisotumab vedotin can be decreased when it is combined with Dabrafenib.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Dabrafenib.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Dabrafenib can be increased when it is combined with Technetium Tc-99m sestamibi.]
[L04AA59, avacopan, The serum concentration of Avacopan can be decreased when it is combined with Dabrafenib.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Clemastine.]
[M01AG01, mefenamic acid, The serum concentration of Mefenamic acid can be decreased when it is combined with Dabrafenib.]
[A10BB12, glimepiride, The serum concentration of Glimepiride can be decreased when it is combined with Dabrafenib.]
[A10BB08, gliquidone, The serum concentration of Gliquidone can be decreased when it is combined with Dabrafenib.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be increased when combined with Dabrafenib.]
[N06AX25, St. John's wort extract, The serum concentration of St. John's Wort can be decreased when it is combined with Dabrafenib.]
[L01EA06, asciminib, The serum concentration of Dabrafenib can be increased when it is combined with Asciminib.]
[L02BG06, exemestane, The serum concentration of Exemestane can be decreased when it is combined with Dabrafenib.]
[J05AX10, maribavir, The serum concentration of Maribavir can be decreased when it is combined with Dabrafenib.]
[D07AD01, clobetasol, The serum concentration of Clobetasol can be decreased when it is combined with Dabrafenib.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be increased when combined with Dabrafenib.]
[J04BA01, clofazimine, The serum concentration of Dabrafenib can be increased when it is combined with Clofazimine.]
[C10AB01, clofibrate, The serum concentration of Clofibrate can be decreased when it is combined with Dabrafenib.]
[B06AX04, mitapivat, The serum concentration of Mitapivat can be decreased when it is combined with Dabrafenib.]
[N01BB10, levobupivacaine, The serum concentration of Levobupivacaine can be decreased when it is combined with Dabrafenib.]
[L01EJ03, pacritinib, The serum concentration of Dabrafenib can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Dabrafenib can be increased when it is combined with Clomifene.]
[N06AA04, clomipramine, The serum concentration of Clomipramine can be decreased when it is combined with Dabrafenib.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Dabrafenib.]
[S01EA04, clonidine, The serum concentration of Clonidine can be decreased when it is combined with Dabrafenib.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Dabrafenib.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be decreased when it is combined with Dabrafenib.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Dabrafenib.]
[A10BX16, tirzepatide, The therapeutic efficacy of Tirzepatide can be decreased when used in combination with Dabrafenib.]
[J02AC06, oteseconazole, The serum concentration of Dabrafenib can be increased when it is combined with Oteseconazole.]
[A02BC08, vonoprazan, Vonoprazan can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H01CC04, linzagolix, The serum concentration of Dabrafenib can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The serum concentration of Clotiazepam can be decreased when it is combined with Dabrafenib.]
[A04AA01, ondansetron, The serum concentration of Ondansetron can be decreased when it is combined with Dabrafenib.]
[A04AA02, granisetron, The serum concentration of Granisetron can be decreased when it is combined with Dabrafenib.]
[J05AX31, lenacapavir, The metabolism of Dabrafenib can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The serum concentration of Clozapine can be decreased when it is combined with Dabrafenib.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be decreased when it is combined with Dabrafenib.]
[A10BX01, guar gum, The therapeutic efficacy of Guar gum can be decreased when used in combination with Dabrafenib.]
[A10BK06, sotagliflozin, The serum concentration of Dabrafenib can be increased when it is combined with Sotagliflozin.]
[H01AC08, somatrogon, The metabolism of Dabrafenib can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The serum concentration of Cocaine can be decreased when it is combined with Dabrafenib.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be decreased when it is combined with Dabrafenib.]
[L04AC21, bimekizumab, The metabolism of Dabrafenib can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The serum concentration of Codeine can be decreased when it is combined with Dabrafenib.]
[M04AC01, colchicine, The metabolism of Colchicine can be decreased when combined with Dabrafenib.]
[L04AA13, leflunomide, The serum concentration of Leflunomide can be decreased when it is combined with Dabrafenib.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Dabrafenib.]
[A10BX03, nateglinide, The serum concentration of Nateglinide can be decreased when it is combined with Dabrafenib.]
[H01AC03, mecasermin, The therapeutic efficacy of Mecasermin can be decreased when used in combination with Dabrafenib.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dabrafenib.]
[J01FA15, telithromycin, The serum concentration of Dabrafenib can be increased when it is combined with Telithromycin.]
[R03BA08, ciclesonide, The serum concentration of Ciclesonide can be decreased when it is combined with Dabrafenib.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Desloratadine.]
[M01AH03, valdecoxib, The serum concentration of Valdecoxib can be decreased when it is combined with Dabrafenib.]
[N02CC05, almotriptan, The serum concentration of Almotriptan can be decreased when it is combined with Dabrafenib.]
[M01AH04, parecoxib, The serum concentration of Parecoxib can be decreased when it is combined with Dabrafenib.]
[J02AC02, itraconazole, The serum concentration of Dabrafenib can be increased when it is combined with Itraconazole.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Dabrafenib.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Emedastine.]
[N05BA10, ketazolam, The serum concentration of Ketazolam can be decreased when it is combined with Dabrafenib.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be decreased when combined with Dabrafenib.]
[L01EA01, imatinib, The serum concentration of Imatinib can be decreased when it is combined with Dabrafenib.]
[J02AC04, posaconazole, The serum concentration of Dabrafenib can be increased when it is combined with Posaconazole.]
[A02BC05, esomeprazole, The serum concentration of Esomeprazole can be decreased when it is combined with Dabrafenib.]
[C08CA09, lacidipine, The serum concentration of Lacidipine can be decreased when it is combined with Dabrafenib.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Dabrafenib.]
[N03AX09, lamotrigine, The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Dabrafenib.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Dabrafenib.]
[S01BA03, cortisone, The metabolism of Dabrafenib can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lofexidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lomefloxacin.]
[R06AX13, loratadine, The serum concentration of Loratadine can be decreased when it is combined with Dabrafenib.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA11, manidipine, The serum concentration of Manidipine can be decreased when it is combined with Dabrafenib.]
[S01BA08, medrysone, The serum concentration of Medrysone can be decreased when it is combined with Dabrafenib.]
[H02AB15, meprednisone, The serum concentration of Meprednisone can be decreased when it is combined with Dabrafenib.]
[R06AD07, mequitazine, The metabolism of Dabrafenib can be decreased when combined with Mequitazine.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Adenosine.]
[C04AX01, cyclandelate, The serum concentration of Cyclandelate can be decreased when it is combined with Dabrafenib.]
[R06AE03, cyclizine, The metabolism of Dabrafenib can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The serum concentration of Eplerenone can be decreased when it is combined with Dabrafenib.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Melperone.]
[J01FA03, midecamycin, The serum concentration of Midecamycin can be decreased when it is combined with Dabrafenib.]
[A10BF02, miglitol, The therapeutic efficacy of Miglitol can be decreased when used in combination with Dabrafenib.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Dabrafenib.]
[L01AA01, cyclophosphamide, The serum concentration of Cyclophosphamide can be decreased when it is combined with Dabrafenib.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be decreased when it is combined with Dabrafenib.]
[N06AG02, moclobemide, The serum concentration of Moclobemide can be decreased when it is combined with Dabrafenib.]
[N06BA07, modafinil, The serum concentration of Modafinil can be decreased when it is combined with Dabrafenib.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Dabrafenib.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Dabrafenib.]
[C10AA07, rosuvastatin, The serum concentration of Rosuvastatin can be decreased when it is combined with Dabrafenib.]
[C03XA02, conivaptan, The serum concentration of Dabrafenib can be increased when it is combined with Conivaptan.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Dabrafenib.]
[M01AH05, etoricoxib, The serum concentration of Etoricoxib can be decreased when it is combined with Dabrafenib.]
[L01DA01, dactinomycin, Dabrafenib may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[G03XA01, danazol, The serum concentration of Dabrafenib can be increased when it is combined with Danazol.]
[J04BA02, dapsone, The serum concentration of Dapsone can be decreased when it is combined with Dabrafenib.]
[L01DB02, daunorubicin, The metabolism of Dabrafenib can be decreased when combined with Daunorubicin.]
[G03XX01, prasterone, The serum concentration of Prasterone can be decreased when it is combined with Dabrafenib.]
[A04AD11, nabilone, The serum concentration of Nabilone can be decreased when it is combined with Dabrafenib.]
[M01AX01, nabumetone, The serum concentration of Nabumetone can be decreased when it is combined with Dabrafenib.]
[C07AB12, nebivolol, The serum concentration of Nebivolol can be decreased when it is combined with Dabrafenib.]
[N06AX06, nefazodone, The serum concentration of Dabrafenib can be increased when it is combined with Nefazodone.]
[L02BB02, nilutamide, The serum concentration of Nilutamide can be decreased when it is combined with Dabrafenib.]
[N03AG06, tiagabine, The serum concentration of Tiagabine can be decreased when it is combined with Dabrafenib.]
[G03DB04, nomegestrol, The serum concentration of Nomegestrol can be decreased when it is combined with Dabrafenib.]
[D11AH02, pimecrolimus, The serum concentration of Pimecrolimus can be decreased when it is combined with Dabrafenib.]
[N06AB10, escitalopram, The serum concentration of Escitalopram can be decreased when it is combined with Dabrafenib.]
[G04BD08, solifenacin, The serum concentration of Solifenacin can be decreased when it is combined with Dabrafenib.]
[N06AA01, desipramine, The metabolism of Dabrafenib can be decreased when combined with Desipramine.]
[S01BA11, desonide, The serum concentration of Desonide can be decreased when it is combined with Dabrafenib.]
[C09XA02, aliskiren, The serum concentration of Aliskiren can be decreased when it is combined with Dabrafenib.]
[L01XA03, oxaliplatin, The serum concentration of Oxaliplatin can be increased when it is combined with Dabrafenib.]
[N03AF02, oxcarbazepine, The metabolism of Dabrafenib can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The serum concentration of Dexamethasone can be decreased when it is combined with Dabrafenib.]
[G04BD04, oxybutynin, The serum concentration of Oxybutynin can be decreased when it is combined with Dabrafenib.]
[L04AB04, adalimumab, The metabolism of Dabrafenib can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The serum concentration of Gefitinib can be decreased when it is combined with Dabrafenib.]
[R05DA09, dextromethorphan, The serum concentration of Dextromethorphan can be decreased when it is combined with Dabrafenib.]
[N03AC01, paramethadione, The serum concentration of Paramethadione can be decreased when it is combined with Dabrafenib.]
[N06AB05, paroxetine, The serum concentration of Paroxetine can be decreased when it is combined with Dabrafenib.]
[B01AC04, clopidogrel, The serum concentration of Clopidogrel can be decreased when it is combined with Dabrafenib.]
[N05BA01, diazepam, The serum concentration of Diazepam can be decreased when it is combined with Dabrafenib.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Cinchocaine.]
[S01BC03, diclofenac, The serum concentration of Diclofenac can be decreased when it is combined with Dabrafenib.]
[J01CF01, dicloxacillin, The metabolism of Dabrafenib can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Dabrafenib.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Dabrafenib.]
[J05AF02, didanosine, The excretion of Didanosine can be decreased when combined with Dabrafenib.]
[C02DG01, pinacidil, The serum concentration of Pinacidil can be decreased when it is combined with Dabrafenib.]
[A03AX04, pinaverium, The serum concentration of Pinaverium can be decreased when it is combined with Dabrafenib.]
[A10BG03, pioglitazone, The serum concentration of Pioglitazone can be increased when it is combined with Dabrafenib.]
[L01DC04, ixabepilone, The serum concentration of Ixabepilone can be decreased when it is combined with Dabrafenib.]
[L01EB02, erlotinib, The serum concentration of Erlotinib can be decreased when it is combined with Dabrafenib.]
[L02AA01, diethylstilbestrol, The serum concentration of Diethylstilbestrol can be decreased when it is combined with Dabrafenib.]
[C08CA03, isradipine, The serum concentration of Isradipine can be decreased when it is combined with Dabrafenib.]
[D07XC04, diflucortolone, The serum concentration of Difluocortolone can be decreased when it is combined with Dabrafenib.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be decreased when it is combined with Dabrafenib.]
[C01AA05, digoxin, The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dabrafenib.]
[C10AX09, ezetimibe, Dabrafenib may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The serum concentration of Dihydroergocristine can be decreased when it is combined with Dabrafenib.]
[N02CA01, dihydroergotamine, The serum concentration of Dihydroergotamine can be decreased when it is combined with Dabrafenib.]
[N02AA03, hydromorphone, The serum concentration of Hydromorphone can be decreased when it is combined with Dabrafenib.]
[J05AE08, atazanavir, The serum concentration of Dabrafenib can be increased when it is combined with Atazanavir.]
[B01AC21, treprostinil, The serum concentration of Treprostinil can be increased when it is combined with Dabrafenib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Pramocaine.]
[D07AC18, prednicarbate, The serum concentration of Prednicarbate can be decreased when it is combined with Dabrafenib.]
[C08DB01, diltiazem, The serum concentration of Diltiazem can be decreased when it is combined with Dabrafenib.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dimenhydrinate.]
[M02AX03, dimethyl sulfoxide, The metabolism of Dabrafenib can be decreased when combined with Dimethyl sulfoxide.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Dabrafenib.]
[C05CA03, diosmin, The serum concentration of Dabrafenib can be increased when it is combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The serum concentration of Diphenhydramine can be decreased when it is combined with Dabrafenib.]
[N05CD10, quazepam, The serum concentration of Quazepam can be decreased when it is combined with Dabrafenib.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Dabrafenib.]
[A03FA02, cisapride, The serum concentration of Cisapride can be decreased when it is combined with Dabrafenib.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be decreased when it is combined with Dabrafenib.]
[C01BA03, disopyramide, The serum concentration of Disopyramide can be decreased when it is combined with Dabrafenib.]
[P03AA04, disulfiram, The serum concentration of Disulfiram can be decreased when it is combined with Dabrafenib.]
[S02AA12, rifamycin SV, The serum concentration of Dabrafenib can be decreased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The serum concentration of Rifapentine can be decreased when it is combined with Dabrafenib.]
[N07XX02, riluzole, Dabrafenib may decrease the excretion rate of Riluzole which could result in a higher serum level.]
[N05AX08, risperidone, The serum concentration of Risperidone can be decreased when it is combined with Dabrafenib.]
[R06AE09, levocetirizine, The serum concentration of Levocetirizine can be decreased when it is combined with Dabrafenib.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Dabrafenib.]
[L01EX01, sunitinib, The serum concentration of Sunitinib can be decreased when it is combined with Dabrafenib.]
[A04AD12, aprepitant, The serum concentration of Aprepitant can be decreased when it is combined with Dabrafenib.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be decreased when it is combined with Dabrafenib.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be decreased when it is combined with Dabrafenib.]
[J05AE07, fosamprenavir, The serum concentration of Fosamprenavir can be decreased when it is combined with Dabrafenib.]
[G04BE08, tadalafil, The serum concentration of Tadalafil can be decreased when it is combined with Dabrafenib.]
[S01BC05, ketorolac, The serum concentration of Ketorolac can be decreased when it is combined with Dabrafenib.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be decreased when it is combined with Dabrafenib.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Dabrafenib.]
[R03AC12, salmeterol, The serum concentration of Dabrafenib can be increased when it is combined with Salmeterol.]
[A03FA03, domperidone, The serum concentration of Domperidone can be decreased when it is combined with Dabrafenib.]
[C01CA04, dopamine, The serum concentration of Dopamine can be increased when it is combined with Dabrafenib.]
[N06AA16, dothiepin, The serum concentration of Dosulepin can be decreased when it is combined with Dabrafenib.]
[N06AA12, doxepin, The serum concentration of Doxepin can be decreased when it is combined with Dabrafenib.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be decreased when it is combined with Dabrafenib.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Dabrafenib.]
[N06AB06, sertraline, The serum concentration of Sertraline can be decreased when it is combined with Dabrafenib.]
[N01AB08, sevoflurane, The serum concentration of Sevoflurane can be decreased when it is combined with Dabrafenib.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Droperidol.]
[A08AA10, sibutramine, The serum concentration of Sibutramine can be decreased when it is combined with Dabrafenib.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be decreased when it is combined with Dabrafenib.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DB01, dydrogesterone, The serum concentration of Dydrogesterone can be decreased when it is combined with Dabrafenib.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sultopride.]
[N02CC01, sumatriptan, Dabrafenib may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[G01AF05, econazole, The serum concentration of Dabrafenib can be increased when it is combined with Econazole.]
[C07AB13, talinolol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Talinolol.]
[H01AA01, corticotropin, The serum concentration of Corticotropin can be decreased when it is combined with Dabrafenib.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Dabrafenib.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Temafloxacin.]
[M01AC02, tenoxicam, The serum concentration of Tenoxicam can be decreased when it is combined with Dabrafenib.]
[D01BA02, terbinafine, The serum concentration of Terbinafine can be decreased when it is combined with Dabrafenib.]
[G04BD05, terodiline, The serum concentration of Terodiline can be decreased when it is combined with Dabrafenib.]
[N06AX14, tianeptine, The serum concentration of Tianeptine can be decreased when it is combined with Dabrafenib.]
[C09AA02, enalapril, The excretion of Enalapril can be decreased when combined with Dabrafenib.]
[M01AG02, tolfenamic acid, The serum concentration of Tolfenamic acid can be decreased when it is combined with Dabrafenib.]
[N06BA09, atomoxetine, The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Dabrafenib.]
[N03AX11, topiramate, The metabolism of Dabrafenib can be increased when combined with Topiramate.]
[L02BA02, toremifene, The serum concentration of Toremifene can be decreased when it is combined with Dabrafenib.]
[C03CA04, torsemide, The serum concentration of Torasemide can be decreased when it is combined with Dabrafenib.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Dabrafenib.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Dabrafenib.]
[L01CA04, vinorelbine, The serum concentration of Vinorelbine can be decreased when it is combined with Dabrafenib.]
[S01GX10, epinastine, The serum concentration of Epinastine can be decreased when it is combined with Dabrafenib.]
[N06AX16, venlafaxine, The serum concentration of Venlafaxine can be decreased when it is combined with Dabrafenib.]
[C08CA12, mepirodipine, The serum concentration of Barnidipine can be decreased when it is combined with Dabrafenib.]
[S01EA01, epinephrine, The metabolism of Dabrafenib can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The serum concentration of Zolpidem can be decreased when it is combined with Dabrafenib.]
[M01AB04, zomepirac, The serum concentration of Zomepirac can be decreased when it is combined with Dabrafenib.]
[N03AX15, zonisamide, The serum concentration of Zonisamide can be decreased when it is combined with Dabrafenib.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Dabrafenib.]
[N05CF01, zopiclone, The serum concentration of Zopiclone can be decreased when it is combined with Dabrafenib.]
[N05AX11, zotepine, The serum concentration of Zotepine can be decreased when it is combined with Dabrafenib.]
[C02AC02, guanfacine, The serum concentration of Guanfacine can be decreased when it is combined with Dabrafenib.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Moricizine is combined with Dabrafenib.]
[G02AB03, ergonovine, The serum concentration of Ergometrine can be decreased when it is combined with Dabrafenib.]
[C04AE01, ergoloid mesylates, USP, The serum concentration of Ergoloid mesylate can be decreased when it is combined with Dabrafenib.]
[N02CA02, ergotamine, The serum concentration of Dabrafenib can be increased when it is combined with Ergotamine.]
[S01AA17, erythromycin, The serum concentration of Erythromycin can be decreased when it is combined with Dabrafenib.]
[N05CD04, estazolam, The serum concentration of Estazolam can be decreased when it is combined with Dabrafenib.]
[A02BC02, pantoprazole, The serum concentration of Pantoprazole can be decreased when it is combined with Dabrafenib.]
[H05BX01, cinacalcet, The serum concentration of Cinacalcet can be decreased when it is combined with Dabrafenib.]
[G03CA03, estradiol, The serum concentration of Estradiol can be decreased when it is combined with Dabrafenib.]
[L01XX11, estramustine, The serum concentration of Estramustine can be decreased when it is combined with Dabrafenib.]
[G03CA57, estrogens, conjugated (USP), The serum concentration of Conjugated estrogens can be decreased when it is combined with Dabrafenib.]
[G03CC04, estrone, The serum concentration of Estrone can be decreased when it is combined with Dabrafenib.]
[J04AK02, ethambutol, The metabolism of Dabrafenib can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The serum concentration of Dabrafenib can be increased when it is combined with Fluticasone furoate.]
[R03BA05, fluticasone, The serum concentration of Dabrafenib can be increased when it is combined with Fluticasone.]
[C10AA04, fluvastatin, The serum concentration of Fluvastatin can be decreased when it is combined with Dabrafenib.]
[L02AA03, ethinyl estradiol, The serum concentration of Ethinylestradiol can be decreased when it is combined with Dabrafenib.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ibutilide.]
[N03AD01, ethosuximide, The serum concentration of Ethosuximide can be decreased when it is combined with Dabrafenib.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The serum concentration of Meloxicam can be decreased when it is combined with Dabrafenib.]
[S01XA06, ethylmorphine, The serum concentration of Ethylmorphine can be decreased when it is combined with Dabrafenib.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be decreased when it is combined with Dabrafenib.]
[N05AE03, sertindole, The serum concentration of Sertindole can be decreased when it is combined with Dabrafenib.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dabrafenib.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Dabrafenib.]
[A02BA04, nizatidine, Nizatidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Dabrafenib.]
[R06AX11, astemizole, The serum concentration of Astemizole can be decreased when it is combined with Dabrafenib.]
[R06AX12, terfenadine, The serum concentration of Dabrafenib can be increased when it is combined with Terfenadine.]
[N06AX12, bupropion, The serum concentration of Bupropion can be decreased when it is combined with Dabrafenib.]
[N06AB08, fluvoxamine, The serum concentration of Fluvoxamine can be decreased when it is combined with Dabrafenib.]
[C01BC08, encainide, The risk or severity of QTc prolongation can be increased when Encainide is combined with Dabrafenib.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Leuprolide.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Dabrafenib.]
[A05AA01, chenodeoxycholic acid, The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Dabrafenib.]
[A02BA03, famotidine, Famotidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Dabrafenib.]
[P02CA03, albendazole, The serum concentration of Albendazole can be decreased when it is combined with Dabrafenib.]
[C08CA02, felodipine, The serum concentration of Dabrafenib can be increased when it is combined with Felodipine.]
[C08EA01, fendiline, The serum concentration of Fendiline can be decreased when it is combined with Dabrafenib.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be decreased when it is combined with Dabrafenib.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Dabrafenib.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Dabrafenib.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Dabrafenib.]
[L04AA40, cladribine, Dabrafenib may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[N07AX03, cevimeline, The serum concentration of Cevimeline can be decreased when it is combined with Dabrafenib.]
[C01BC04, flecainide, The metabolism of Dabrafenib can be decreased when combined with Flecainide.]
[J01CF05, floxacillin, The metabolism of Dabrafenib can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The serum concentration of Dabrafenib can be increased when it is combined with Fluconazole.]
[H02AA02, fludrocortisone, The serum concentration of Fludrocortisone can be decreased when it is combined with Dabrafenib.]
[D07XB01, flumethasone, The serum concentration of Flumethasone can be decreased when it is combined with Dabrafenib.]
[N07CA03, flunarizine, The serum concentration of Flunarizine can be decreased when it is combined with Dabrafenib.]
[N05CD03, flunitrazepam, The serum concentration of Flunitrazepam can be decreased when it is combined with Dabrafenib.]
[D07AC08, fluocinonide, The serum concentration of Fluocinonide can be decreased when it is combined with Dabrafenib.]
[H02AB03, fluocortolone, The serum concentration of Fluocortolone can be decreased when it is combined with Dabrafenib.]
[V03AZ01, ethanol, The serum concentration of Ethanol can be decreased when it is combined with Dabrafenib.]
[L01BC09, floxuridine, The metabolism of Dabrafenib can be decreased when combined with Floxuridine.]
[S01CB05, fluorometholone, The serum concentration of Fluorometholone can be decreased when it is combined with Dabrafenib.]
[L01BC02, fluorouracil, The serum concentration of Fluorouracil can be decreased when it is combined with Dabrafenib.]
[N06AB03, fluoxetine, The serum concentration of Fluoxetine can be decreased when it is combined with Dabrafenib.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Flupentixol.]
[D07AC07, flurandrenolide, The serum concentration of Flurandrenolide can be decreased when it is combined with Dabrafenib.]
[N05CD01, flurazepam, The serum concentration of Flurazepam can be decreased when it is combined with Dabrafenib.]
[S01BC04, flurbiprofen, The serum concentration of Flurbiprofen can be decreased when it is combined with Dabrafenib.]
[N05AG01, fluspirilene, The serum concentration of Fluspirilene can be decreased when it is combined with Dabrafenib.]
[L02BB01, flutamide, The serum concentration of Flutamide can be decreased when it is combined with Dabrafenib.]
[V04CX02, folic acid, Dabrafenib may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The serum concentration of Tegafur can be decreased when it is combined with Dabrafenib.]
[J05AE10, darunavir, The serum concentration of Dabrafenib can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, The metabolism of Furosemide can be decreased when combined with Dabrafenib.]
[N05CF04, eszopiclone, The serum concentration of Eszopiclone can be decreased when it is combined with Dabrafenib.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Dabrafenib.]
[N06DA04, galantamine, The serum concentration of Galantamine can be decreased when it is combined with Dabrafenib.]
[C08DA02, gallopamil, The serum concentration of Gallopamil can be decreased when it is combined with Dabrafenib.]
[N03AA04, barbexaclone, The metabolism of Dabrafenib can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The serum concentration of Dabrafenib can be increased when it is combined with Gemfibrozil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Dabrafenib.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be decreased when it is combined with Dabrafenib.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be decreased when it is combined with Dabrafenib.]
[A10BJ02, liraglutide, The therapeutic efficacy of Liraglutide can be decreased when used in combination with Dabrafenib.]
[J05AG04, etravirine, The serum concentration of Etravirine can be decreased when it is combined with Dabrafenib.]
[N03AD03, methsuximide, The serum concentration of Methsuximide can be decreased when it is combined with Dabrafenib.]
[G03XA02, gestrinone, The serum concentration of Gestrinone can be decreased when it is combined with Dabrafenib.]
[N01AH02, alfentanil, The serum concentration of Alfentanil can be decreased when it is combined with Dabrafenib.]
[L01EH01, lapatinib, The serum concentration of Lapatinib can be decreased when it is combined with Dabrafenib.]
[A10BB01, glyburide, The serum concentration of Glyburide can be decreased when it is combined with Dabrafenib.]
[A10BB09, gliclazide, The serum concentration of Gliclazide can be decreased when it is combined with Dabrafenib.]
[A10BB07, glipizide, The serum concentration of Glipizide can be decreased when it is combined with Dabrafenib.]
[C01BD04, dofetilide, The serum concentration of Dofetilide can be decreased when it is combined with Dabrafenib.]
[C02CA04, doxazosin, The serum concentration of Doxazosin can be decreased when it is combined with Dabrafenib.]
[L01EX02, sorafenib, The serum concentration of Dabrafenib can be increased when it is combined with Sorafenib.]
[C07AB09, esmolol, The risk or severity of QTc prolongation can be increased when Esmolol is combined with Dabrafenib.]
[B01AA12, fluindione, The serum concentration of Fluindione can be decreased when it is combined with Dabrafenib.]
[D01BA01, griseofulvin, The metabolism of Dabrafenib can be increased when combined with Griseofulvin.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Goserelin.]
[P01BX01, halofantrine, The serum concentration of Halofantrine can be decreased when it is combined with Dabrafenib.]
[D07AD02, halcinonide, The serum concentration of Halcinonide can be decreased when it is combined with Dabrafenib.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Haloperidol.]
[N01AB01, halothane, The serum concentration of Halothane can be decreased when it is combined with Dabrafenib.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dabrafenib.]
[N05AH04, quetiapine, The serum concentration of Quetiapine can be decreased when it is combined with Dabrafenib.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Dabrafenib.]
[L01CE02, irinotecan, The risk or severity of neutropenia can be increased when Dabrafenib is combined with Irinotecan.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Dabrafenib.]
[C09CA01, losartan, The serum concentration of Losartan can be decreased when it is combined with Dabrafenib.]
[G03DC01, allylestrenol, The serum concentration of Allylestrenol can be decreased when it is combined with Dabrafenib.]
[A07EC02, mesalamine, The excretion of Mesalazine can be decreased when combined with Dabrafenib.]
[N05CA16, hexobarbital, The serum concentration of Hexobarbital can be decreased when it is combined with Dabrafenib.]
[J05AG01, nevirapine, The serum concentration of Nevirapine can be decreased when it is combined with Dabrafenib.]
[C08CA10, nilvadipine, The serum concentration of Nilvadipine can be decreased when it is combined with Dabrafenib.]
[M02AA26, nimesulide, The serum concentration of Nimesulide can be decreased when it is combined with Dabrafenib.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Oxatomide.]
[C02DB02, hydralazine, The metabolism of Dabrafenib can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Dabrafenib.]
[R05DA03, hydrocodone, The serum concentration of Hydrocodone can be decreased when it is combined with Dabrafenib.]
[S02BA01, hydrocortisone, The serum concentration of Hydrocortisone can be decreased when it is combined with Dabrafenib.]
[D07AC16, hydrocortisone aceponate, The serum concentration of Hydrocortisone aceponate can be decreased when it is combined with Dabrafenib.]
[D07AB11, hydrocortisone probutate, The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Dabrafenib.]
[G04BD06, propiverine, The serum concentration of Propiverine can be decreased when it is combined with Dabrafenib.]
[P01BA02, hydroxychloroquine, The serum concentration of Hydroxychloroquine can be decreased when it is combined with Dabrafenib.]
[G03DA03, 17-alpha-hydroxyprogesterone, The serum concentration of Hydroxyprogesterone can be decreased when it is combined with Dabrafenib.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Hydroxyzine.]
[J04AB04, rifabutin, The serum concentration of Rifabutin can be decreased when it is combined with Dabrafenib.]
[S01BA13, rimexolone, The serum concentration of Rimexolone can be decreased when it is combined with Dabrafenib.]
[R02AX02, ibuprofen, The serum concentration of Ibuprofen can be decreased when it is combined with Dabrafenib.]
[L01DB06, idarubicin, The serum concentration of Idarubicin can be decreased when it is combined with Dabrafenib.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Dabrafenib.]
[N01AH03, sufentanil, The serum concentration of Sufentanil can be decreased when it is combined with Dabrafenib.]
[N06AA02, imipramine, The serum concentration of Imipramine can be decreased when it is combined with Dabrafenib.]
[L01CD01, paclitaxel, The serum concentration of Paclitaxel can be decreased when it is combined with Dabrafenib.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Terlipressin.]
[M03BX02, tizanidine, The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Dabrafenib.]
[L01CE01, topotecan, Dabrafenib may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, The serum concentration of Indapamide can be decreased when it is combined with Dabrafenib.]
[S01BC01, indomethacin, The serum concentration of Indomethacin can be decreased when it is combined with Dabrafenib.]
[N06AX17, milnacipran, The serum concentration of Milnacipran can be decreased when it is combined with Dabrafenib.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Dabrafenib.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Articaine.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be decreased when it is combined with Dabrafenib.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Dabrafenib.]
[N05CH02, ramelteon, The serum concentration of Ramelteon can be decreased when it is combined with Dabrafenib.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dabrafenib.]
[A10BH02, vildagliptin, The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Dabrafenib.]
[C10AA06, cerivastatin, The serum concentration of Cerivastatin can be decreased when it is combined with Dabrafenib.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Anagrelide.]
[V03AB01, ipecac, The serum concentration of Ipecac can be decreased when it is combined with Dabrafenib.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Dabrafenib.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Dabrafenib.]
[N06AF05, iproniazid, The metabolism of Dabrafenib can be decreased when combined with Iproniazid.]
[D06BB10, imiquimod, The serum concentration of Imiquimod can be decreased when it is combined with Dabrafenib.]
[P01AX06, atovaquone, The serum concentration of Atovaquone can be decreased when it is combined with Dabrafenib.]
[N01AB06, isoflurane, The serum concentration of Isoflurane can be decreased when it is combined with Dabrafenib.]
[J04AC01, isoniazid, The metabolism of Dabrafenib can be decreased when combined with Isoniazid.]
[A10BJ01, exenatide, The therapeutic efficacy of Exenatide can be decreased when used in combination with Dabrafenib.]
[D10BA01, isotretinoin, The serum concentration of Isotretinoin can be decreased when it is combined with Dabrafenib.]
[P02CF01, ivermectin, The serum concentration of Ivermectin can be decreased when it is combined with Dabrafenib.]
[N06AX18, reboxetine, The serum concentration of Reboxetine can be decreased when it is combined with Dabrafenib.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Dabrafenib can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The serum concentration of Ketamine can be decreased when it is combined with Dabrafenib.]
[B01AC22, prasugrel, The serum concentration of Prasugrel can be decreased when it is combined with Dabrafenib.]
[J02AB02, ketoconazole, The serum concentration of Dabrafenib can be increased when it is combined with Ketoconazole.]
[H02CA04, levoketoconazole, The serum concentration of Dabrafenib can be increased when it is combined with Levoketoconazole.]
[N05AH03, olanzapine, Olanzapine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M02AA10, ketoprofen, The metabolism of Dabrafenib can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Dabrafenib can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Dabrafenib can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mizolastine.]
[N04BC09, rotigotine, The serum concentration of Rotigotine can be decreased when it is combined with Dabrafenib.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Nalidixic acid.]
[C07AG01, labetalol, The serum concentration of Labetalol can be decreased when it is combined with Dabrafenib.]
[N04BB01, amantadine, The serum concentration of Amantadine can be increased when it is combined with Dabrafenib.]
[J05AX09, maraviroc, The serum concentration of Maraviroc can be decreased when it is combined with Dabrafenib.]
[N03AX18, lacosamide, The serum concentration of Lacosamide can be decreased when it is combined with Dabrafenib.]
[R05CB06, ambroxol, The serum concentration of Ambroxol can be decreased when it is combined with Dabrafenib.]
[G03AD01, levonorgestrel, The serum concentration of Levonorgestrel can be decreased when it is combined with Dabrafenib.]
[S02DA01, lidocaine, The serum concentration of Lidocaine can be decreased when it is combined with Dabrafenib.]
[C08EX01, lidoflazine, The serum concentration of Lidoflazine can be decreased when it is combined with Dabrafenib.]
[N06BA13, armodafinil, The metabolism of Dabrafenib can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Dabrafenib.]
[N02CA07, lisuride, The serum concentration of Lisuride can be decreased when it is combined with Dabrafenib.]
[A07DA03, loperamide, The serum concentration of Loperamide can be decreased when it is combined with Dabrafenib.]
[N05BA06, lorazepam, The serum concentration of Lorazepam can be decreased when it is combined with Dabrafenib.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Dabrafenib.]
[N05AH01, loxapine, The serum concentration of Dabrafenib can be increased when it is combined with Loxapine.]
[G03DC03, lynestrenol, The serum concentration of Lynestrenol can be decreased when it is combined with Dabrafenib.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be decreased when it is combined with Dabrafenib.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[P03AX03, malathion, The serum concentration of Malathion can be decreased when it is combined with Dabrafenib.]
[L01BA05, pralatrexate, Dabrafenib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The serum concentration of Dabrafenib can be increased when it is combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Dabrafenib can be increased when it is combined with Mannitol.]
[N06AA21, maprotiline, The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dabrafenib.]
[G03DB03, medrogestone, The serum concentration of Medrogestone can be decreased when it is combined with Dabrafenib.]
[P01BC02, mefloquine, The serum concentration of Mefloquine can be decreased when it is combined with Dabrafenib.]
[N06DX01, memantine, The serum concentration of Memantine can be increased when it is combined with Dabrafenib.]
[N02AB02, meperidine, The serum concentration of Meperidine can be decreased when it is combined with Dabrafenib.]
[N03AB04, mephenytoin, The serum concentration of Mephenytoin can be decreased when it is combined with Dabrafenib.]
[N03AA01, mephobarbital, The serum concentration of Methylphenobarbital can be decreased when it is combined with Dabrafenib.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Dabrafenib can be increased when combined with Aminoglutethimide.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mesoridazine.]
[N05AX13, paliperidone, The serum concentration of Paliperidone can be decreased when it is combined with Dabrafenib.]
[A10BA02, metformin, The therapeutic efficacy of Metformin can be decreased when used in combination with Dabrafenib.]
[A04AA04, dolasetron, The serum concentration of Dolasetron can be decreased when it is combined with Dabrafenib.]
[H01CB03, lanreotide, The metabolism of Dabrafenib can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The serum concentration of Methadone can be decreased when it is combined with Dabrafenib.]
[A03AB07, methantheline, Methantheline can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CM01, methaqualone, The serum concentration of Methaqualone can be decreased when it is combined with Dabrafenib.]
[J05AF05, lamivudine, Dabrafenib may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[H03BB02, methimazole, The serum concentration of Dabrafenib can be increased when it is combined with Methimazole.]
[L01BA04, pemetrexed, Dabrafenib may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[L04AX03, methotrexate, The serum concentration of Methotrexate can be decreased when it is combined with Dabrafenib.]
[N05AA02, methotrimeprazine, The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Dabrafenib.]
[N02BG09, methoxyflurane, The serum concentration of Methoxyflurane can be decreased when it is combined with Dabrafenib.]
[V04CG05, methylene blue, The serum concentration of Methylene blue can be decreased when it is combined with Dabrafenib.]
[G02AB01, methylergonovine, The serum concentration of Methylergometrine can be decreased when it is combined with Dabrafenib.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be decreased when it is combined with Dabrafenib.]
[H02AB04, methylprednisolone, The serum concentration of Methylprednisolone can be decreased when it is combined with Dabrafenib.]
[N03AF03, rufinamide, The metabolism of Dabrafenib can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, The serum concentration of Methyltestosterone can be decreased when it is combined with Dabrafenib.]
[N02CA04, methysergide, The serum concentration of Methysergide can be decreased when it is combined with Dabrafenib.]
[A03FA01, metoclopramide, The serum concentration of Metoclopramide can be decreased when it is combined with Dabrafenib.]
[P01AB01, metronidazole, The metabolism of Dabrafenib can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Dabrafenib can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, The serum concentration of Mexiletine can be decreased when it is combined with Dabrafenib.]
[N06AX03, mianserin, The serum concentration of Mianserin can be decreased when it is combined with Dabrafenib.]
[S02AA13, miconazole, The metabolism of Dabrafenib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The serum concentration of Aminophenazone can be decreased when it is combined with Dabrafenib.]
[N05CD08, midazolam, The serum concentration of Midazolam can be decreased when it is combined with Dabrafenib.]
[G03XB01, mifepristone, The serum concentration of Dabrafenib can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The serum concentration of Valsartan can be decreased when it is combined with Dabrafenib.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be decreased when combined with Dabrafenib.]
[J01FA11, miocamycin, The metabolism of Dabrafenib can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The serum concentration of Dabrafenib can be decreased when it is combined with Mitotane.]
[L01DB07, mitoxantrone, Dabrafenib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[L03AC01, aldesleukin, The metabolism of Dabrafenib can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The serum concentration of Dabrafenib can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The serum concentration of Amitriptyline can be decreased when it is combined with Dabrafenib.]
[N02AA01, morphine, The serum concentration of Morphine can be decreased when it is combined with Dabrafenib.]
[A04AA05, palonosetron, The serum concentration of Palonosetron can be decreased when it is combined with Dabrafenib.]
[L04AB05, certolizumab pegol, The metabolism of Dabrafenib can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The serum concentration of Eltrombopag can be decreased when it is combined with Dabrafenib.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be decreased when it is combined with Dabrafenib.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be decreased when combined with Dabrafenib.]
[N05CA02, amobarbital, The metabolism of Dabrafenib can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be decreased when combined with Dabrafenib.]
[P01BA06, amodiaquine, The serum concentration of Amodiaquine can be decreased when it is combined with Dabrafenib.]
[G04CA04, silodosin, The serum concentration of Silodosin can be decreased when it is combined with Dabrafenib.]
[G03XC01, raloxifene, The metabolism of Dabrafenib can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Dabrafenib.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be decreased when it is combined with Dabrafenib.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Dabrafenib is combined with Ropinirole.]
[J01CF06, nafcillin, The metabolism of Dabrafenib can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The serum concentration of Dabrafenib can be increased when it is combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be decreased when combined with Dabrafenib.]
[L04AC03, anakinra, The metabolism of Dabrafenib can be increased when combined with Anakinra.]
[M02AA12, naproxen, The serum concentration of Naproxen can be decreased when it is combined with Dabrafenib.]
[A10BG01, troglitazone, The serum concentration of Troglitazone can be decreased when it is combined with Dabrafenib.]
[N06AX21, duloxetine, The serum concentration of Duloxetine can be decreased when it is combined with Dabrafenib.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Dabrafenib.]
[L01CD02, docetaxel, The serum concentration of Docetaxel can be decreased when it is combined with Dabrafenib.]
[L02BG04, letrozole, The serum concentration of Letrozole can be decreased when it is combined with Dabrafenib.]
[A10BX02, repaglinide, The serum concentration of Repaglinide can be decreased when it is combined with Dabrafenib.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Levosimendan.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Dabrafenib.]
[N06AX23, desvenlafaxine, The serum concentration of Desvenlafaxine can be decreased when it is combined with Dabrafenib.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Dabrafenib which could result in a higher serum level.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Dabrafenib.]
[M04AA03, febuxostat, The excretion of Dabrafenib can be decreased when combined with Febuxostat.]
[H05BX02, paricalcitol, The serum concentration of Paricalcitol can be decreased when it is combined with Dabrafenib.]
[C10AD02, niacin, The metabolism of Dabrafenib can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The serum concentration of Nicardipine can be decreased when it is combined with Dabrafenib.]
[P02DA01, niclosamide, The serum concentration of Niclosamide can be decreased when it is combined with Dabrafenib.]
[N07BA01, nicotine, The serum concentration of Nicotine can be decreased when it is combined with Dabrafenib.]
[C08CA05, nifedipine, The serum concentration of Nifedipine can be decreased when it is combined with Dabrafenib.]
[C08CA06, nimodipine, The serum concentration of Nimodipine can be decreased when it is combined with Dabrafenib.]
[C08CA07, nisoldipine, The serum concentration of Nisoldipine can be decreased when it is combined with Dabrafenib.]
[N05CD02, nitrazepam, The serum concentration of Nitrazepam can be decreased when it is combined with Dabrafenib.]
[C08CA08, nitrendipine, The serum concentration of Nitrendipine can be decreased when it is combined with Dabrafenib.]
[J01XE01, nitrofurantoin, Dabrafenib may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The serum concentration of Zaleplon can be decreased when it is combined with Dabrafenib.]
[N04BC05, pramipexole, The serum concentration of Pramipexole can be increased when it is combined with Dabrafenib.]
[C01CA03, norepinephrine, The serum concentration of Norepinephrine can be increased when it is combined with Dabrafenib.]
[G03DC02, norethindrone, The serum concentration of Norethisterone can be decreased when it is combined with Dabrafenib.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Dabrafenib.]
[G03AC07, norgestrienone, The serum concentration of Norgestrienone can be decreased when it is combined with Dabrafenib.]
[C02KX01, bosentan, The serum concentration of Bosentan can be decreased when it is combined with Dabrafenib.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be decreased when it is combined with Dabrafenib.]
[R05DA07, noscapine, The metabolism of Dabrafenib can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, The serum concentration of Dabrafenib can be increased when it is combined with Sapropterin.]
[G02CA02, nylidrin, The serum concentration of Nylidrin can be decreased when it is combined with Dabrafenib.]
[H01CB02, octreotide, The serum concentration of Dabrafenib can be increased when it is combined with Octreotide.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Dabrafenib can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Dabrafenib can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The serum concentration of Omeprazole can be decreased when it is combined with Dabrafenib.]
[N02AA02, opium, The serum concentration of Opium can be decreased when it is combined with Dabrafenib.]
[G04CA02, tamsulosin, The serum concentration of Tamsulosin can be decreased when it is combined with Dabrafenib.]
[C01AC01, ouabain, The excretion of Ouabain can be decreased when combined with Dabrafenib.]
[A14AA08, oxandrolone, The metabolism of Dabrafenib can be decreased when combined with Oxandrolone.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Oxolinic acid.]
[N02AA05, oxycodone, The serum concentration of Oxycodone can be decreased when it is combined with Dabrafenib.]
[N02AA11, oxymorphone, The serum concentration of Oxymorphone can be decreased when it is combined with Dabrafenib.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Dabrafenib.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dabrafenib.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Dabrafenib.]
[N05AH05, asenapine, The serum concentration of Asenapine can be decreased when it is combined with Dabrafenib.]
[G03DB06, chlormadinone, The serum concentration of Chlormadinone can be decreased when it is combined with Dabrafenib.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Papaverine.]
[H02AB05, paramethasone, The serum concentration of Paramethasone can be decreased when it is combined with Dabrafenib.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Dabrafenib.]
[G04BD11, fesoterodine, The serum concentration of Fesoterodine can be decreased when it is combined with Dabrafenib.]
[N05AG03, penfluridol, The serum concentration of Penfluridol can be decreased when it is combined with Dabrafenib.]
[M01CC01, penicillamine, The excretion of Penicillamine can be decreased when combined with Dabrafenib.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Dabrafenib.]
[N05CA01, pentobarbital, The serum concentration of Pentobarbital can be decreased when it is combined with Dabrafenib.]
[C08EX02, perhexiline, The serum concentration of Perhexiline can be decreased when it is combined with Dabrafenib.]
[N02BE03, phenacetin, The serum concentration of Phenacetin can be decreased when it is combined with Dabrafenib.]
[A10BA01, phenformin, The therapeutic efficacy of Phenformin can be decreased when used in combination with Dabrafenib.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Dabrafenib.]
[N03AA02, phenobarbital, The serum concentration of Phenobarbital can be decreased when it is combined with Dabrafenib.]
[B01AA04, phenprocoumon, The serum concentration of Phenprocoumon can be decreased when it is combined with Dabrafenib.]
[A08AA01, phentermine, The serum concentration of Phentermine can be decreased when it is combined with Dabrafenib.]
[M02AA01, phenylbutazone, The serum concentration of Phenylbutazone can be decreased when it is combined with Dabrafenib.]
[A02BC06, dexlansoprazole, The serum concentration of Dexlansoprazole can be decreased when it is combined with Dabrafenib.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be decreased when it is combined with Dabrafenib.]
[L04AB06, golimumab, The metabolism of Dabrafenib can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Levofloxacin.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Dabrafenib.]
[L02BB03, bicalutamide, The serum concentration of Bicalutamide can be decreased when it is combined with Dabrafenib.]
[J05AB12, cidofovir, The excretion of Cidofovir can be decreased when combined with Dabrafenib.]
[C08CX01, mibefradil, The serum concentration of Mibefradil can be decreased when it is combined with Dabrafenib.]
[N05AG02, pimozide, The serum concentration of Pimozide can be decreased when it is combined with Dabrafenib.]
[C10AA05, atorvastatin, The metabolism of Atorvastatin can be decreased when combined with Dabrafenib.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Dabrafenib.]
[J05AE01, saquinavir, The serum concentration of Dabrafenib can be increased when it is combined with Saquinavir.]
[N05AC04, pipothiazine, The serum concentration of Pipotiazine can be decreased when it is combined with Dabrafenib.]
[S01BC06, piroxicam, The serum concentration of Piroxicam can be decreased when it is combined with Dabrafenib.]
[J01MA11, grepafloxacin, The serum concentration of Grepafloxacin can be decreased when it is combined with Dabrafenib.]
[J05AG02, delavirdine, The serum concentration of Dabrafenib can be increased when it is combined with Delavirdine.]
[C09CA04, irbesartan, The serum concentration of Irbesartan can be decreased when it is combined with Dabrafenib.]
[D05AX05, tazarotene, The serum concentration of Tazarotene can be decreased when it is combined with Dabrafenib.]
[A10BG02, rosiglitazone, The serum concentration of Rosiglitazone can be decreased when it is combined with Dabrafenib.]
[L02BG03, anastrozole, The serum concentration of Anastrozole can be decreased when it is combined with Dabrafenib.]
[A03AE01, alosetron, The serum concentration of Alosetron can be decreased when it is combined with Dabrafenib.]
[L04AC08, canakinumab, The metabolism of Dabrafenib can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Dabrafenib.]
[J05AE03, ritonavir, The serum concentration of Dabrafenib can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The serum concentration of Saxagliptin can be decreased when it is combined with Dabrafenib.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dabrafenib.]
[C10AA08, pitavastatin, The serum concentration of Pitavastatin can be decreased when it is combined with Dabrafenib.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Prajmaline.]
[N05BA11, prazepam, The serum concentration of Prazepam can be decreased when it is combined with Dabrafenib.]
[P02BA01, praziquantel, The serum concentration of Praziquantel can be decreased when it is combined with Dabrafenib.]
[C02CA01, prazosin, Dabrafenib may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[S03BA02, prednisolone, The serum concentration of Prednisolone can be decreased when it is combined with Dabrafenib.]
[H02AB07, prednisone, The serum concentration of Prednisone can be decreased when it is combined with Dabrafenib.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Antazoline.]
[C01DX02, prenylamine, The serum concentration of Prenylamine can be decreased when it is combined with Dabrafenib.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Prilocaine.]
[P01BA03, primaquine, The serum concentration of Primaquine can be decreased when it is combined with Dabrafenib.]
[N03AA03, primidone, The serum concentration of Primidone can be decreased when it is combined with Dabrafenib.]
[M04AB01, probenecid, The metabolism of Dabrafenib can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Probucol.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Dabrafenib.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Dabrafenib is combined with Procaine.]
[C10AB05, fenofibrate, The serum concentration of Fenofibrate can be decreased when it is combined with Dabrafenib.]
[N05AB04, prochlorperazine, The serum concentration of Prochlorperazine can be decreased when it is combined with Dabrafenib.]
[G03DA04, progesterone, The serum concentration of Progesterone can be decreased when it is combined with Dabrafenib.]
[N05AA03, promazine, The serum concentration of Promazine can be decreased when it is combined with Dabrafenib.]
[G03DB07, promegestone, The serum concentration of Promegestone can be decreased when it is combined with Dabrafenib.]
[R06AD02, promethazine, The serum concentration of Promethazine can be decreased when it is combined with Dabrafenib.]
[C01BC03, propafenone, The serum concentration of Propafenone can be decreased when it is combined with Dabrafenib.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Dabrafenib.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be decreased when it is combined with Dabrafenib.]
[N01AX10, propofol, The serum concentration of Propofol can be decreased when it is combined with Dabrafenib.]
[N02AC04, propoxyphene, The serum concentration of Dextropropoxyphene can be decreased when it is combined with Dabrafenib.]
[C07AA05, propranolol, The serum concentration of Propranolol can be decreased when it is combined with Dabrafenib.]
[R03DC03, montelukast, The serum concentration of Montelukast can be decreased when it is combined with Dabrafenib.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Dabrafenib.]
[N05AX12, aripiprazole, The serum concentration of Aripiprazole can be decreased when it is combined with Dabrafenib.]
[N07XX07, dalfampridine, The serum concentration of Dalfampridine can be increased when it is combined with Dabrafenib.]
[R06AC01, pyrilamine, The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Dabrafenib.]
[P01BD01, pyrimethamine, The metabolism of Dabrafenib can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The serum concentration of Quinacrine can be decreased when it is combined with Dabrafenib.]
[C01BA01, quinidine, The serum concentration of Quinidine can be decreased when it is combined with Dabrafenib.]
[P01BC01, quinine, The serum concentration of Quinine can be decreased when it is combined with Dabrafenib.]
[A02BA02, ranitidine, Ranitidine can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C02AA02, reserpine, The serum concentration of Dabrafenib can be increased when it is combined with Reserpine.]
[J04AB02, rifampin, The serum concentration of Dabrafenib can be decreased when it is combined with Rifampicin.]
[J01FA06, roxithromycin, The serum concentration of Roxithromycin can be decreased when it is combined with Dabrafenib.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Dabrafenib which could result in a higher serum level.]
[S01BC08, salicylic acid, The serum concentration of Salicylic acid can be decreased when it is combined with Dabrafenib.]
[S01FA02, scopolamine, The serum concentration of Scopolamine can be decreased when it is combined with Dabrafenib.]
[N05CA06, secobarbital, The serum concentration of Dabrafenib can be decreased when it is combined with Secobarbital.]
[N04BD01, selegiline, The serum concentration of Selegiline can be decreased when it is combined with Dabrafenib.]
[V04CC03, sincalide, The excretion of Sincalide can be decreased when combined with Dabrafenib.]
[H01CB01, somatostatin, The metabolism of Dabrafenib can be decreased when combined with Somatostatin.]
[C07AA07, sotalol, The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sotalol.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be decreased when it is combined with Dabrafenib.]
[C03DA01, spironolactone, The metabolism of Dabrafenib can be decreased when combined with Spironolactone.]
[J05AF08, adefovir dipivoxil, The excretion of Adefovir dipivoxil can be decreased when combined with Dabrafenib.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be decreased when it is combined with Dabrafenib.]
[N03AG01, valproic acid, The serum concentration of Valproic acid can be decreased when it is combined with Dabrafenib.]
[D07AB02, hydrocortisone butyrate, The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Dabrafenib.]
